Table 1.
Distribution of GM* and KM phenotypes in the XAGE-1b antibody-positive and-negative patients with lung adenocarcinoma (n = 89).
| Phenotype | XAGE-1b antibody |
||||
|---|---|---|---|---|---|
| Positive (n = 29) | (%) | Negative (n = 60) | (%) | P-value | |
| GM 1,17 21 | 0 | 0 | 10 | 16·7 | 0·027 |
| GM 1,2,17 21 | 15 | 51·7 | 19 | 31·7 | 0·06 |
| GM 1,17 13,21 | 0 | 0 | 4 | 6·7 | 0·30 |
| GM 1,2,17 13,21 | 1 | 3·4 | 8 | 13·3 | 0·26 |
| GM 1,2,3,17 23 5,13,21 | 2 | 6·9 | 5 | 8·3 | 1·0 |
| Other GM | 11 | 37·9 | 14 | 23·3 | 0·21 |
| KM 1 | 3 | 10·3 | 6 | 10·0 | 0·61 |
| KM 1,3 | 8 | 27·6 | 26 | 43·3 | 0·15 |
| KM 3 | 11 | 62·1 | 28 | 46·7 | 0·17 |
*
Fisher's exact test (6 × 2), P = 0·023.